Alzheimer’s disease (AD) is a global public health issue that is becoming increasingly prevalent. Morocco faces particular difficulties because of its inadequate infrastructure and healthcare resources. There are many chances to improve Alzheimer’s disease care in this situation by integrating artificial intelligence (AI) technology such as machine learning and neural networks. This study examines the opportunities and problems of managing and analyzing health data in Morocco, as well as how AI may help with early diagnosis, tailored therapy, and caregiver support. By examining brain imaging, genetic markers, and other biomarkers, AI-driven diagnostic models hold significant potential for detecting early Alzheimer’s symptoms and for making more precise and effective predictions about how the illness will advance than conventional techniques. This is especially important for Morocco, where early detection might decrease the disease’s long-term social and economic costs. Additionally, AI-generated personalized treatment strategies can be customized to each patient’s unique profile, accounting for Moroccan-specific genetic, environmental, and lifestyle factors. Furthermore, AI-driven caregiver assistance systems may track patient behavior, identify declining trends, and provide useful insights, reducing the mental and physical strain on caretakers. In a cultural setting where family members are frequently responsible for providing care, these tools have the potential to be transformative. The effective use of AI in Alzheimer’s disease treatment in Morocco, however, depends on strong infrastructure for managing medical data. To guarantee that patient data are collected and analyzed effectively, issues such as data privacy, interoperability, standardization, and equitable access must be resolved. Furthermore, the legal and ethical frameworks controlling AI use in healthcare must be modified to reflect regional differences. This article emphasizes how AI can change Alzheimer’s care in Morocco and stresses the necessity of a multidisciplinary strategy involving researchers, technologists, healthcare professionals, and legislators. Morocco can enhance the quality of life for Alzheimer’s patients and their families while also advancing the management of neurodegenerative diseases globally by utilizing AI technologies and addressing related issues.